• 2024
  Brunet J, Choucha Z, Gransagne M, Tabbal H, Ku M-W, Buchrieser J, Fernandes P, Batalie D, Lopez J, Ma L, Dufour E, Simon E, Hardy D, Petres S, Guinet F, Strick-Marchand H, Monot M, Charneau P, Majlessi L, Duprex WP, Gerke C, Martin A, Escriou N, A measles-vectored vaccine candidate expressing prefusion-stabilized SARS-CoV-2 spike protein brought to phase I/II clinical trials: candidate selection in a preclinical murine model., J Virol 2024 Apr; (): e0169323.
• 2022
  Vesin B, Lopez J, Noirat A, Authié P, Fert I, Le Chevalier F, Moncoq F, Nemirov K, Blanc C, Planchais C, Mouquet H, Guinet F, Hardy D, Vives FL, Gerke C, Anna F, Bourgine M, Majlessi L, Charneau P, , An intranasal lentiviral booster reinforces the waning mRNA vaccine-induced SARS-CoV-2 immunity that it targets to lung mucosa., Mol Ther 2022 Apr; (): .
• 2022
  , Safety and immunogenicity of a measles-vectored SARS-CoV-2 vaccine candidate, V591 / TMV-083, in healthy adults: results of a randomized, placebo-controlled Phase I study, .
• 2022
  Launay O, Artaud C, Lachâtre M, Ait-Ahmed M, Klein J, Luong Nguyen LB, Durier C, Jansen B, Tomberger Y, Jolly N, Grossmann A, Tabbal H, Brunet J, Gransagne M, Choucha Z, Batalie D, Delgado A, Müllner M, Tschismarov R, Berghmans PJ, Martin A, Ramsauer K, Escriou N, Gerke C, , Safety and immunogenicity of a measles-vectored SARS-CoV-2 vaccine candidate, V591 / TMV-083, in healthy adults: results of a randomized, placebo-controlled Phase I study., EBioMedicine 2022 Jan; 75(): 103810.
• 2020
  Derbise A, Guillas C, Gerke C, Carniel E, Pizarro-Cerdà J, Demeure CE, Subcutaneous vaccination with a live attenuated Yersinia pseudotuberculosis plague vaccine, Vaccine 2020 Jan;.
• 2019
  Roth C, Cantaert T, Colas C, Prot M, Casadémont I, Levillayer L, Thalmensi J, Langlade-Demoyen P, Gerke C, Bahl K, Ciaramella G, Simon-Loriere E, Sakuntabhai A, A Modified mRNA Vaccine Targeting Immunodominant NS Epitopes Protects Against Dengue Virus Infection in HLA Class I Transgenic Mice, Front. Immunol. 2019 Jun;10 (1424).
• 2018
  Demeure CE, Derbise A, Guillas C, Gerke C, Cauchemez S, Carniel E, Pizarro-Cerdá J, , Humoral and cellular immune correlates of protection against bubonic plague by a live Yersinia pseudotuberculosis vaccine., Vaccine 2019 01; 37(1): 123-129.
• 2017
  Launay O., D.J.M. Lewis, A. Anemona, P. Loulergue, J. Leahy, A.S. Sciré, A. Maugard, E. Marchetti, S. Zancan, Z. Huo, S. Rondini, R. Marhaba, O. Finco, L.B. Martin, J. Auerbach, D. Cohen, A. Saul, C. Gerke, and A. Podda, Safety Profile and Immunologic Responses of a Novel Vaccine Against Shigella sonnei Administered Intramuscularly, Intradermally and Intranasally: Results From Two Parallel Randomized Phase 1 Clinical Studies in Healthy Adult Volunteers in Europe, EBioMedicine. 2017 Aug;22:164-172.
• 2016
  Rossi O., M. Caboni, A. Negrea, F. Necchi, R. Alifini, F. Micoli, A. Saul, C.A. MacLennan, S. Rondini, and C. Gerke., TLR activation by Generalized Modules for membrane Antigens (GMMA) from lipid A mutants of Salmonella enterica serovars Typhimurium and Enteritidis, Clin Vaccine Immunol. 2016 Apr 4;23(4):304-14.
• 2015
  Thompson C.N., T.P. Le, K.L. Anders, T.H. Nguyen, L.V. Lu, V.V. Nguyen, T.D. Vu, N.M. Nguyen, T.H. Tran, T.T. Ha, V.T. Tran, V. M. Pham, H.N. Tran, T.Q. Le, A. Saul, L.B. Martin, A. Podda A, C. Gerke, G. Thwaites, C.P. Simmons, and S. Bake, The transfer and decay of maternal antibody against Shigella sonnei in a longitudinal cohort of Vietnamese infants, Vaccine. 2016 Feb 3;34(6):783-90.
• 2015
  Maggiore L., L. Yu, U. Omasits, O. Rossi, G. Dougan, N.R. Thomson, A. Saul, J.S. Choudary, and C. Gerke, Quantitative proteomic analysis of Shigella flexneri and Shigella sonnei Generalized Modules for Membrane Antigens (GMMA) reveals highly pure preparations, Int J Med Microbiol. 2016 Feb;306(2):99-108.
• 2015
  Gerke C., A.M. Colucci, C. Giannelli, S. Sanzone, C.G. Vitali, L. Sollai, O. Rossi, L.B. Martin, J. Auerbach, V. Di Cioccio, and A. Saul, Production of a Shigella sonnei vaccine based on Generalized Modules for Membrane Antigens (GMMA), 1790GAHB, PLoS One. 2015 Aug 6;10(8):e0134478.
• 2014
  Rossi O., L. Maggiore, F. Necchi, O. Koeberling, C.A. MacLennan, A. Saul, and C. Gerke, Comparison of colorimetric assays with quantitative amino acid analysis for protein quantification of Generalized Modules for Membrane Antigens (GMMA), Mol Biotechnol. 2015 Jan;57(1):84-93.
• 2014
  Rossi O., I. Pesce, C. Giannelli, S. Aprea, M. Caboni, F. Citiulo, S. Valentini, I. Ferlenghi, C.A. MacLennan, U. D’Oro, A. Saul, and C. Gerke, Modulation of Endotoxicity of Shigella Generalized Modules for Membrane Antigens (GMMA) by Genetic Lipid A Modifications: Relative Activation of TLR4 and TLR2 Pathways in Different Mutants, J Biol Chem. 2014 Sep 5;289(36):24922-35.
• 2012
  Berlanda-Scorza, F., A.M. Colucci, L. Maggiore, S. Sanzone, I. Pesce, I. Ferlenghi, N. Norais, V. Di Cioccio, A. Saul, and C. Gerke, High Yield Production Process for Shigella Outer Membrane Particles, PLoS One. 2012;7(6):e35616.
• 2010
  Craig V.J., I. Arnold, C. Gerke, M.Q. Huynh, T. Wündisch, A. Neubauer, C. Renner, S. Falkow, and A. Müller, Gastric MALT lymphoma B cells express polyreactive, somatically mutated immunoglobulins, Blood. 2010 Jan 21;115(3):581-91.
• 2009
  McLaughlin L.M., G.R. Govoni, C. Gerke, S. Gopinath, K. Peng, G. Laidlaw, Y.-h. Chien, H.W. Jeong, Z. Li, M.D. Brown, D. B. Sacks, and D. M. Monack, The Salmonella SPI2 effector SseI mediates long-term systemic infection by modulating host cell migration, PLoS Pathog. 2009 Nov;5(11):e1000671.
• 2009
  Craig V.J., S.B. Cogliatti, I. Arnold, C. Gerke, J.E. Balandat, T. Wündisch, and A. Müller, B-cell receptor signaling and CD40 ligand-independent T cell help cooperate in Helicobacter-induced MALT lymphomagenesis, Leukemia. 2010 Jun;24(6):1186-96.
• 2009
  Lodoen M.B., C. Gerke, and J.C. Boothroyd, A highly sensitive FRET-based approach reveals secretion of the actin-binding protein toxofilin during Toxoplasma gondii infection, Cell Microbiol. 2010 Jan;12(1):55-66..
• 2007
  Lawley, T. D., D. M. Bouley, Y. E. Hoy, C. Gerke, D. A. Relman, and D.M. Monack, Host transmission of Salmonella enterica serovar Typhimurium is controlled by virulence factors and the indigenous intestinal microbiota, Infect Immun. 2008 Jan;76(1):403-16.
• 2005
  Gerke, C., S. Falkow, and Y-h. Chien, The adaptor molecules LAT and SLP-76 are specifically targeted by Yersinia to inhibit T cell activation, J Exp Med. 2005 Feb 7;201(3):361-71.
• 2003
  Vuong, C., C. Gerke, G.A. Somerville, E.R. Fischer, and M. Otto, Quorum-sensing control of biofilm factors in Staphylococcus epidermidis, J Infect Dis. 2003 Sep 1;188(5):706-18.
• 2001
  Cramton, S.E., C. Gerke, and F. Götz, In vitro methods to study staphylococcal biofilm formation, Methods Enzymol. 2001;336:239-5518..
• 1999
  Cramton, S.E., C. Gerke, N.F. Schnell, N.W. Nichols, and F. Götz, The intercellular adhesion (ica) locus is present in Staphylococcus aureus and is required for biofilm formation, Infect Immun. 1999 Oct;67(10):5427-33.
• 1998
  Gerke, C., A. Kraft, R. Süßmuth, O. Schweitzer, and F. Götz, Characterization of the N-acetylglucosaminyltransferase activity involved in the biosynthesis of the Staphylococcus epidermidis polysaccharide intercellular adhesin, J Biol Chem. 1998 Jul 17;273(29):18586-93.
• 1996
  Heilmann, C., O. Schweitzer, C. Gerke, N. Vanittanakom, D. Mack, and F. Götz, Molecular basis of intercellular adhesion in the biofilm-forming Staphylococcus epidermidis, Mol Microbiol. 1996 Jun;20(5):1083-91..
• 1996
  Heilmann, C., C. Gerke, F. Perdreau-Remington, and F. Götz, Characterization of Tn917 insertion mutants of Staphylococcus epidermidis affected in biofilm formation, Infect Immun. 1996 Jan;64(1):277-82.